Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Robinson

Showing results (1161-1170 of 1,209) with videos related to

Pageof 121
Sort By:
Neuro-Oncology|June 2, 2022
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A Upadhyaya, Olivia Campagne, Catherine A Billups, et al.
Nature Communications|September 29, 2018
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptomeMichael Rusch, Joy Nakitandwe, Sheila Shurtleff, et al.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|May 19, 2025
Independent and interactive effects of disease and methylmercury on demographic rates across multiple amphibian populationsMorgan P Kain, Blake R Hossack, Kelly L Smalling, et al.
Neuro-Oncology|April 8, 2022
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.
Oncogene|November 28, 2018
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemiaKaren A Urtishak, Li-San Wang, Biljana Culjkovic-Kraljacic, et al.
Nature|September 21, 2022
Unified rhombic lip origins of group 3 and group 4 medulloblastomaKyle S Smith, Laure Bihannic, Brian L Gudenas, et al.
Acta Neuropathologica|August 11, 2025
Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysisMargit K Mikkelsen, Xiaoyu Li, Kaiwen Yu, et al.
Journal of Medicinal Chemistry|August 26, 2009
Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activityClaudio Mapelli, Sesha I Natarajan, Jean-Philippe Meyer, et al.
Pageof 121

Showing results (1161-1170 of 1,209) with videos related to

Sort By:
Pageof 121
Neuro-Oncology|June 2, 2022
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A Upadhyaya, Olivia Campagne, Catherine A Billups, et al.
Nature Communications|September 29, 2018
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptomeMichael Rusch, Joy Nakitandwe, Sheila Shurtleff, et al.
Genome Medicine|May 31, 2022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaJenette Creaney, Ann-Marie Patch, Venkateswar Addala, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|May 19, 2025
Independent and interactive effects of disease and methylmercury on demographic rates across multiple amphibian populationsMorgan P Kain, Blake R Hossack, Kelly L Smalling, et al.
Neuro-Oncology|April 8, 2022
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.
Oncogene|November 28, 2018
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemiaKaren A Urtishak, Li-San Wang, Biljana Culjkovic-Kraljacic, et al.
Nature|September 21, 2022
Unified rhombic lip origins of group 3 and group 4 medulloblastomaKyle S Smith, Laure Bihannic, Brian L Gudenas, et al.
Acta Neuropathologica|August 11, 2025
Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysisMargit K Mikkelsen, Xiaoyu Li, Kaiwen Yu, et al.
Journal of Medicinal Chemistry|August 26, 2009
Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activityClaudio Mapelli, Sesha I Natarajan, Jean-Philippe Meyer, et al.
Pageof 121